BioVie Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMedix

BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company") today announced the closing of its previously announced acquisition of the biopharmaceutical assets of NeurMedix, Inc., a privately held clinical-stage pharmaceutical company.